Information Presentation Formats

NCT ID: NCT02267928

Last Updated: 2016-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

305 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prevention and early detection of medical problems can greatly reduce health care costs, yet time and again, people avoid or ignore services that could help detect medical problems early enough to prevent or reduce the severity of potential problems. The investigators seek to understand whether the elicitation of symptom admission by patients can predict people's perceived risk of the medical condition and voluntary pursuit of medical information.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We will present individuals with medically accurate information about a medical condition and measure people's perceptions of their own likelihood to having that medical condition. This will include an opportunity for people to pursue more information by directing them to a website that features more information about the condition. The initial information provision will vary slightly in presentation (method of eliciting symptoms will vary), and the rate at which individuals visit the subsequent medical website to receive more information will be recorded as a measure of information seeking behavior. Rates will be compared across symptom elicitation conditions to determine which formats are most effective at encouraging information seeking about health issues. No personally identifying information will be collected, and all results will be reported in aggregate. Critically, no deception will be used: Participants will only be provided with information that is as accurate as possible (given existing knowledge in the health/medical fields).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Meningioma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Check/Experience

Participants are asked to check the symptoms that they have experienced in the last 6 weeks.

Group Type EXPERIMENTAL

Check Symptoms

Intervention Type OTHER

Symptoms are "Checked"

Experienced

Intervention Type OTHER

Focus of instructions is on symptoms the participant has experienced

Un-check/Experience

Participants are asked to un-check the symptoms that they have experienced in the last 6 weeks.

Group Type EXPERIMENTAL

Uncheck Symptoms

Intervention Type OTHER

Symptoms are "Un-checked"

Experienced

Intervention Type OTHER

Focus of instructions is on symptoms the participant has experienced

Check/Not Experienced

Participants are asked to check the symptoms that they have NOT experienced in the last 6 weeks.

Group Type EXPERIMENTAL

Check Symptoms

Intervention Type OTHER

Symptoms are "Checked"

Not Experienced

Intervention Type OTHER

Focus of instructions is on symptoms the participant has NOT experienced

Un-check/Not Experienced

Participants are asked to un-check the symptoms that they have NOT experienced in the last 6 weeks.

Group Type EXPERIMENTAL

Uncheck Symptoms

Intervention Type OTHER

Symptoms are "Un-checked"

Not Experienced

Intervention Type OTHER

Focus of instructions is on symptoms the participant has NOT experienced

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Check Symptoms

Symptoms are "Checked"

Intervention Type OTHER

Uncheck Symptoms

Symptoms are "Un-checked"

Intervention Type OTHER

Experienced

Focus of instructions is on symptoms the participant has experienced

Intervention Type OTHER

Not Experienced

Focus of instructions is on symptoms the participant has NOT experienced

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 or older
* American

Exclusion Criteria

* Mechanical Turk approval rate below 95%
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Carnegie Mellon University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eric VanEpps

PhD Candidate

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eric M VanEpps, MS

Role: PRINCIPAL_INVESTIGATOR

Carnegie Mellon University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Carnegie Mellon University

Pittsburgh, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HS14-574

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Communicating Multiple Disease Risks
NCT02621671 COMPLETED PHASE1